Cell Signaling Technology

Stat1/2/3/5 Control Cell Extracts

#9133 · $165

100
Citing papers
6.1k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer9Neuroinflammation and Neurodegeneration Mechanisms7RNA Research and Splicing6Epigenetics and DNA Methylation6Ubiquitin and proteasome pathways5MicroRNA in disease regulation5Histone Deacetylase Inhibitors Research4Cancer-related gene regulation4

Papers citing this product

1
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
Genes & Development·2003·825 cit.·DOI
2
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ
Journal of Clinical Investigation·2003·712 cit.·DOI
3
Chemokine CCL2–CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus
Journal of Neuroscience·2017·214 cit.·DOI
4
Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling
PLoS Biology·2016·189 cit.·DOI
5
Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells
Pharmacological Research·2013·172 cit.·DOI
6
Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration Induced<i>In Vivo</i>by 3-Nitropropionate: Implications for Huntington's Disease
Journal of Neuroscience·2003·160 cit.·DOI
7
Modulation of Heat-shock Protein 27 (Hsp27) Anti-apoptotic Activity by Methylglyoxal Modification
Journal of Biological Chemistry·2002·140 cit.·DOI
8
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
Molecular & Cellular Proteomics·2009·124 cit.·DOI
9
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Molecular Cancer·2012·121 cit.·DOI
10
(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
Carcinogenesis·2011·117 cit.·DOI